Critical considerations for developing nucleic acid macromolecule based drug products

Drug Discovery Today

Volumn 21, Issue 3, 2016, Pages 430-444

  Muralidhara, Bilikallahalli K ^a   Baid, Rinku ^a   Bishop, Steve M ^a   Huang, Min ^b   Wang, Wei ^b   Nema, Sandeep ^b  

^a MEDIMMUNE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ANALYTIC METHOD; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; HUMAN; MACROMOLECULE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REVIEW; SHELF LIFE; TARGET CELL; CHEMISTRY;

DRUG COMPOUNDING; DRUG STABILITY; NUCLEIC ACIDS;

EID: 84953439628     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.11.012     Document Type: Review

References (108)

1. S.L. Ginn, and et al. Gene therapy clinical trials worldwide to 2012 - an update J. Gene Med. 15 2013 65 77
2. J.J. Donnelly, and et al. Protective efficacy of intramuscular immunization with naked DNA Ann. N. Y. Acad. Sci. 772 1995 40 46
3. C. Pollard, and et al. Challenges and advances towards the rational design of mRNA vaccines Trends Mol. Med. 19 2013 705 713
4. T. Schlake, and et al. Developing mRNA-vaccine technologies RNA Biol. 9 2012 1319 1330
5. B. Petsch, and et al. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection Nat. Biotechnol. 30 2012 1210 1216
6. A.K. Roos, and et al. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation Mol. Ther. 13 2006 320 327
7. B.A. Sullenger Targeted genetic repair: an emerging approach to genetic therapy J. Clin. Invest. 112 2003 310 311
8. P. Zarogoulidis, and et al. Suicide gene therapy for cancer - current strategies J. Genet. Syndr. Gene Ther. 4 2013 pii:16849
9. J. Rice, and et al. DNA vaccines: precision tools for activating effective immunity against cancer Nat. Rev. Cancer 8 2008 108 120
10. S. Kreiter, and et al. Tumor vaccination using messenger RNA: prospects of a future therapy Curr. Opin. Immunol. 23 2011 399 406
11. S. Gurunathan, and et al. DNA vaccines: immunology, application, and optimization Annu. Rev. Immunol. 18 2000 927 974
12. E.J. Ryan, and et al. Immunomodulators and delivery systems for vaccination by mucosal routes Trends Biotechnol. 19 2001 293 304
13. H. Yin, and et al. Non-viral vectors for gene-based therapy Nat. Rev. Genet. 15 2014 541 555
14. J.J. Donnelly, and et al. DNA vaccines: progress and challenges J. Immunol. 175 2005 633 639
15. M.S. Draz, and et al. Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections Theranostics 4 2014 872 892
16. M.A. Islam, and et al. Major degradable polycations as carriers for DNA and siRNA J. Control. Release 193 2014 74 89
17. D. Pogocki, and C. Schoneich Chemical stability of nucleic acid-derived drugs J. Pharm. Sci. 89 2000 443 456
18. R.K. Evans, and et al. Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies J. Pharm. Sci. 89 2000 76 87
19. T. Lindahl, and B. Nyberg Rate of depurination of native deoxyribonucleic acid Biochemistry 11 1972 3610 3618
20. B.A. Lobo, and et al. Differential scanning calorimetric studies of the thermal stability of plasmid DNA complexed with cationic lipids and polymers J. Pharm. Sci. 91 2002 454 466
21. G. Barone, and et al. Effect of osmoregulatory solutes on the thermal stability of calf-thymus DNA Faraday Trans. 92 1996 1361 1367
22. C.R. Middaugh, and et al. Analysis of plasmid DNA from a pharmaceutical perspective J. Pharm. Sci. 87 1998 130 146
23. T. Lindahl, and A. Andersson Rate of chain breakage at apurinic sites in double-stranded deoxyribonucleic acid Biochemistry 11 1972 3618 3623
24. H. Sugiyama, and et al. Chemistry of thermal degradation of abasic sites in DNA. Mechanistic investigation on thermal DNA strand cleavage of alkylated DNA Chem. Res. Toxicol. 7 1994 673 683
25. H.J. Choi, and et al. Turbulent drag reduction and degradation of DNA Phys. Rev. Lett. 89 2002 088302
26. C.S. Lengsfeld, and T.J. Anchordoquy Shear-induced degradation of plasmid DNA J. Pharm. Sci. 91 2002 1581 1589
27. E.R. Arulmuthu, and et al. Studies on aerosol delivery of plasmid DNA using a mesh nebulizer Biotechnol. Bioeng. 98 2007 939 955
28. F.J. Meacle, and et al. Degradation of supercoiled plasmid DNA within a capillary device Biotechnol. Bioeng. 97 2007 1148 1157
29. Y.K. Lentz, and et al. Effect of jet nemulization on DNA: identifying the dominant degradation mechanims and mitigation methods J. Aerosol. Sci. 36 2005 973 990
30. J. Lynch, and et al. Factors controlling particle size during nebulization of DNA-polycation complexes J. Aerosol. Med. 20 2007 257 268
31. T.J. Anchordoquy, and et al. Physical stabilization of DNA-based therapeutics Drug Discov. Today 6 2001 463 470
32. W. Shao, and et al. Characterization of effect of repeated freeze and thaw cycles on stability of genomic DNA using pulsed field gel electrophoresis Biopreserv. Biobank 10 2012 4 11
33. M.C. Molina, and T.J. Anchordoquy Metal contaminants promote degradation of lipid/DNA complexes during lyophilization Biochim. Biophys. Acta 1768 2007 669 677
34. T. Lindahl Instability and decay of the primary structure of DNA Nature 362 1993 709 715
35. H. Maeda, and et al. Degradation of DNA into 5′-monodeoxyribonucleotides in the presence of Mn(2+) ions Biosci. Biotechnol. Biochem. 71 2007 2670 2679
36. N. Schweigert, and et al. DNA degradation by the mixture of copper and catechol is caused by DNA-copper-hydroperoxo complexes, probably DNA-Cu(I)OOH Environ. Mol. Mutagen 36 2000 5 12
37. S. Frelon, and et al. Hydroxyl radical is not the main reactive species involved in the degradation of DNA bases by copper in the presence of hydrogen peroxide Chem. Res. Toxicol. 16 2003 191 197
38. P. Muniz, and et al. Differences between cysteine and homocysteine in the induction of deoxyribose degradation and DNA damage Free Radic. Biol. Med. 30 2001 354 362
39. S.C. Sahu, and M.C. Washington Effect of ascorbic acid and curcumin on quercetin-induced nuclear DNA damage, lipid peroxidation and protein degradation Cancer Lett. 63 1992 237 241
40. L. Strekowski, and et al. A biphasic nature of the bleomycin-mediated degradation of DNA FEBS Lett. 241 1988 24 28
41. J.M. Choi, and et al. Antioxidant properties of neohesperidin dihydrochalcone: inhibition of hypochlorous acid-induced DNA strand breakage, protein degradation, and cell death Biol. Pharm. Bull. 30 2007 324 330
42. L. Marrot, and P.U. Giacomoni Enhancement of oxidative DNA degradation by histidine: the role of stereochemical parameters Mutat. Res. 275 1992 69 79
43. T. Bauer, and et al. Effect of food components and processing parameters on DNA degradation in food Environ. Biosafety Res. 3 2004 215 223
44. R. Shapiro, and R.S. Klein The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications Biochemistry 5 1966 2358 2362
45. K. Tanaka, and A. Okamoto Degradation of DNA by bisulfite treatment Bioorg. Med. Chem. Lett. 17 2007 1912 1915
46. F.W. Chaplen, and et al. Detection of methylglyoxal as a degradation product of DNA and nucleic acid components treated with strong acid Anal. Biochem. 236 1996 262 269
47. C.N. Mount, and et al. The influence of physico-chemical and process conditions on the physical stability of plasmid DNA complexes using response surface methodology Biotechnol. Appl. Biochem. 37 2003 225 234
48. T. Douki, and et al. Protection against radiation-induced degradation of DNA bases by polyamines Radiat. Res. 153 2000 29 35
49. M.J. Molloy, and et al. Effective and robust plasmid topology analysis and the subsequent characterization of the plasmid isoforms thereby observed Nucleic Acids Res. 32 2004 e129
50. C.R. Smith, and et al. Separation of topological forms of plasmid DNA by anion-exchange HPLC: shifts in elution order of linear DNA J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 854 2007 121 127
51. G. Raucci, and et al. Capillary electrophoresis of supercoiled DNA molecules: parameters governing the resolution of topoisomers and their separation from open forms Anal. Chem. 72 2000 821 826
52. J.L. Zabzdyr, and S.J. Lillard UV- and visible-excited fluorescence of nucleic acids separated by capillary electrophoresis J. Chromatogr. A 911 2001 269 276
53. E. Fundador, and J. Rusling Detection of labeled abasic sites in damaged DNA by capillary electrophoresis with laser-induced fluorescence Anal. Bioanal. Chem. 387 2007 1883 1890
54. J.I. Friedman, and J.T. Stivers Detection of damaged DNA bases by DNA glycosylase enzymes Biochemistry 49 2010 4957 4967
55. I. Stier, and A. Kiss Cytosine-to-uracil deamination by SssI DNA methyltransferase PLoS One 8 2013 e79003
56. B.C. Blount, and B.N. Ames Analysis of uracil in DNA by gas chromatography-mass spectrometry Anal. Biochem. 219 1994 195 200
57. S. Giatrellis, and G. Nounesis Nucleic acid-lipid membrane interactions studied by DSC J. Pharm. Bioallied Sci. 3 2011 70 76
58. C.J. Pachuk, and et al. DNA vaccines - challenges in delivery Curr. Opin. Mol. Ther. 2 2000 188 198
59. D.J. Wells Intramuscular injection of plasmid DNA Mol. Cell. Biol. Hum. Dis. Ser. 5 1995 83 103
60. S. Coulman, and et al. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy Crit. Rev. Ther. Drug Carrier Syst. 23 2006 205 258
61. N. Meykadeh, and et al. Topical application of plasmid DNA to mouse and human skin J. Mol. Med. 83 2005 897 903
62. S. Babiuk, and et al. Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix) J. Pharm. Pharmacol. 54 2002 1609 1614
63. K. Raviprakash, and K.R. Porter Needle-free injection of DNA vaccines: a brief overview and methodology Methods Mol. Med. 127 2006 83 89
64. A. Goubier, and et al. Superiority of needle-free transdermal plasmid delivery for the induction of antigen-specific IFNgamma T cell responses in the dog Vaccine 26 2008 2186 2190
65. Y. Hattori, and et al. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route J. Pharmacol. Exp. Ther. 318 2006 828 834
66. X.P. Wang, and et al. Intravenous delivery of liposome-mediated nonviral DNA is less toxic than intraperitoneal delivery in mice World J. Surg. 29 2005 339 343
67. M.J. Lee, and et al. Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model Gene Ther. 9 2002 859 866
68. D.L. Reimer, and et al. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates J. Pharmacol. Exp. Ther. 289 1999 807 815
69. Y. Higuchi, and et al. Suppression of TNFalpha production in LPS induced liver failure in mice after intravenous injection of cationic liposomes/NFkappaB decoy complex Pharmazie 61 2006 144 147
70. Y. Hattori, and et al. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route J. Control. Release 108 2005 484 495
71. V. Floch, and et al. Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency Biochim. Biophys. Acta 1464 2000 95 103
72. K. Bowman, and K.W. Leong Chitosan nanoparticles for oral drug and gene delivery Int. J. Nanomed. 1 2006 117 128
73. M. George, and T.E. Abraham Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review J. Control. Release 114 2006 1 14
74. S. Jain, and et al. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B Immunol. Lett. 101 2005 41 49
75. S. Somavarapu, and et al. Oral plasmid DNA delivery systems for genetic immunisation J. Drug Target. 11 2003 547 553
76. T.W. Kim, and et al. Induction of immunity against hepatitis B virus surface antigen by intranasal DNA vaccination using a cationic emulsion as a mucosal gene carrier Mol. Cells 22 2006 175 181
77. N. Csaba, and et al. PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery J. Control. Release 113 2006 164 172
78. M. Koping-Hoggard, and et al. Nanoparticles as carriers for nasal vaccine delivery Expert Rev. Vaccines 4 2005 185 196
79. W. Xu, and et al. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection Vaccine 22 2004 3603 3612
80. A. Kichler, and et al. Intranasal gene delivery with a polyethylenimine-PEG conjugate J. Control. Release 81 2002 379 388
81. J. Birchall Pulmonary delivery of nucleic acids Expert Opin. Drug Deliv. 4 2007 575 578
82. Y.K. Lentz, and et al. Rationale for the selection of an aerosol delivery system for gene delivery J. Aerosol. Med. 19 2006 372 384
83. C.L. Densmore Advances in noninvasive pulmonary gene therapy Curr. Drug Deliv. 3 2006 55 63
84. F. Mohamed, and C.F. van der Walle PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA Int. J. Pharm. 311 2006 97 107
85. H.O. Alpar, and et al. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery Adv. Drug Deliv. Rev. 57 2005 411 430
86. P.W. Lee, and et al. The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery Biomaterials 29 2008 742 751
87. H.S. Gill, and M.R. Prausnitz Coated microneedles for transdermal delivery J. Control. Release 117 2007 227 237
88. T.E. Zewert, and et al. Transdermal transport of DNA antisense oligonucleotides by electroporation Biochem. Biophys. Res. Commun. 212 1995 286 292
89. K. Kawabata, and et al. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake Pharm. Res. 12 1995 825 830
90. Y. Yang, and et al. Cross-linked low molecular weight glycopeptide-mediated gene delivery: relationship between DNA metabolic stability and the level of transient gene expression in vivo J. Pharm. Sci. 90 2001 2010 2022
91. H.Q. Mao, and et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency J. Control. Release 70 2001 399 421
92. C.M. Wiethoff, and C.R. Middaugh Barriers to nonviral gene delivery J. Pharm. Sci. 92 2003 203 217
93. D.Y. Kwoh, and et al. Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver Biochim. Biophys. Acta 1444 1999 171 190
94. S.W. Hui, and et al. The role of helper lipids in cationic liposome-mediated gene transfer Biophys. J. 71 1996 590 599
95. G. Widera, and et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo J. Immunol. 164 2000 4635 4640
96. L.R. Palmer, and et al. Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids Biochim. Biophys. Acta 1611 2003 204 216
97. M.E. Davis Non-viral gene delivery systems Curr. Opin. Biotechnol. 13 2002 128 131
98. P. Midoux, and et al. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells Nucleic Acids Res. 21 1993 871 878
99. S. Takae, and et al. PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors J. Am. Chem. Soc. 130 2008 6001 6009
100. Y. Tu, and J.S. Kim A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes J. Gene Med. 10 2008 646 654
101. J.J. Ludtke, and et al. A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA J. Cell Sci. 112 1999 2033 2041
102. F. Zhang, and et al. A transfecting peptide derived from adenovirus fiber protein Gene Ther. 6 1999 171 181
103. M.A. Zanta, and et al. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus Proc. Natl. Acad. Sci. U. S. A. 96 1999 91 96
104. R.C. Carlisle, and et al. Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors Mol. Ther. 4 2001 473 483
105. H. Pollard, and et al. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells J. Biol. Chem. 273 1998 7507 7511
106. D.A. Dean, and et al. Nuclear targeting of plasmid DNA in human corneal cells Curr. Eye Res. 19 1999 66 75
107. D.A. Dean, and et al. Sequence requirements for plasmid nuclear import Exp. Cell Res. 253 1999 713 722
108. J.E. Ledgerwood, and et al. A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial J. Infect. Dis. 203 2011 1396 1404